Comparative Prognosis of HER2-Low versus HER2-Negative Breast Cancer: A Meta-Analysis.

Li Y, Chen T, Tang C, Cui H, Li C

Open source

DOI
10.2174/0118715206404939251124112505
Published
2026 Mar 12
Container
Anti-cancer agents in medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0118715206404939251124112505,
  title = {Comparative Prognosis of HER2-Low versus HER2-Negative Breast Cancer: A Meta-Analysis.},
  author = {Li Y and Chen T and Tang C and Cui H and Li C},
  year = {2026},
  journal = {Anti-cancer agents in medicinal chemistry},
  doi = {10.2174/0118715206404939251124112505},
  url = {https://doi.org/10.2174/0118715206404939251124112505}
}

RIS

TY  - JOUR
TI  - Comparative Prognosis of HER2-Low versus HER2-Negative Breast Cancer: A Meta-Analysis.
AU  - Li Y
AU  - Chen T
AU  - Tang C
AU  - Cui H
AU  - Li C
PY  - 2026
JO  - Anti-cancer agents in medicinal chemistry
DO  - 10.2174/0118715206404939251124112505
UR  - https://doi.org/10.2174/0118715206404939251124112505
ER  - 

APA

Y, L., T, C., C, T., H, C., & C, L. (2026). Comparative Prognosis of HER2-Low versus HER2-Negative Breast Cancer: A Meta-Analysis.. Anti-cancer agents in medicinal chemistry. https://doi.org/10.2174/0118715206404939251124112505

Source records